Renaissance Technologies LLC grew its stake in shares of Atrion Co. (NASDAQ:ATRI) by 2.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 59,700 shares of the medical instruments supplier’s stock after acquiring an additional 1,500 shares during the period. Renaissance Technologies LLC owned about 3.23% of Atrion worth $37,647,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Citadel Advisors LLC bought a new stake in shares of Atrion during the fourth quarter valued at approximately $269,000. Teacher Retirement System of Texas bought a new stake in shares of Atrion during the fourth quarter valued at approximately $323,000. Bank of Montreal Can raised its stake in shares of Atrion by 25.7% during the fourth quarter. Bank of Montreal Can now owns 597 shares of the medical instruments supplier’s stock valued at $376,000 after acquiring an additional 122 shares in the last quarter. Advisor Group Inc. raised its stake in shares of Atrion by 5,826.7% during the third quarter. Advisor Group Inc. now owns 889 shares of the medical instruments supplier’s stock valued at $598,000 after acquiring an additional 874 shares in the last quarter. Finally, Spark Investment Management LLC bought a new stake in shares of Atrion during the fourth quarter valued at approximately $756,000. 59.05% of the stock is owned by hedge funds and other institutional investors.
Separately, BidaskClub downgraded shares of Atrion from a “sell” rating to a “strong sell” rating in a research note on Monday, December 18th.
Atrion stock opened at $606.50 on Monday. The company has a market cap of $1,122.81, a P/E ratio of 32.80 and a beta of 0.70. Atrion Co. has a 12 month low of $459.50 and a 12 month high of $694.00.
Atrion (NASDAQ:ATRI) last issued its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $4.66 EPS for the quarter. The company had revenue of $34.02 million during the quarter. Atrion had a net margin of 24.96% and a return on equity of 19.53%.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Thursday, March 15th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Wednesday, March 14th. Atrion’s dividend payout ratio (DPR) is 24.35%.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/03/19/atrion-co-atri-shares-bought-by-renaissance-technologies-llc.html.
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRI).
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.